Efficacy in pigs of inactivated and live attenuated influenza virus vaccines against infection and transmission of an emerging H3N2 similar to the 2011-2012 H3N2v.
about
Optimal Use of Vaccines for Control of Influenza A Virus in SwinePhylogenetic analysis of a swine influenza A(H3N2) virus isolated in Korea in 2012A Phylogeny-Based Global Nomenclature System and Automated Annotation Tool for H1 Hemagglutinin Genes from Swine Influenza A Viruses.Harnessing Local Immunity for an Effective Universal Swine Influenza VaccineReverse zoonosis of influenza to swine: new perspectives on the human-animal interface.Heterologous challenge in the presence of maternally-derived antibodies results in vaccine-associated enhanced respiratory disease in weaned piglets.α-Galactosylceramide protects swine against influenza infection when administered as a vaccine adjuvant.Age at Vaccination and Timing of Infection Do Not Alter Vaccine-Associated Enhanced Respiratory Disease in Influenza A Virus-Infected Pigs.Aerosol Delivery of a Candidate Universal Influenza Vaccine Reduces Viral Load in Pigs Challenged with Pandemic H1N1 Virus.Distinct immune responses and virus shedding in pigs following aerosol, intra-nasal and contact infection with pandemic swine influenza A virus, A(H1N1)09Pigs with Severe Combined Immunodeficiency Are Impaired in Controlling Influenza A Virus Infection.Development of an Alternative Modified Live Influenza B Virus Vaccine.Oral Fluids as a Live-Animal Sample Source for Evaluating Cross-Reactivity and Cross-Protection following Intranasal Influenza A Virus Vaccination in Pigs.Maternally-derived antibodies do not prevent transmission of swine influenza A virus between pigs.The Molecular Determinants of Antibody Recognition and Antigenic Drift in the H3 Hemagglutinin of Swine Influenza A Virus.Exploration of risk factors contributing to the presence of influenza A virus in swine at agricultural fairs.Substitutions near the hemagglutinin receptor-binding site determine the antigenic evolution of influenza A H3N2 viruses in U.S. swine.Prevalence of Influenza A Virus in Exhibition Swine during Arrival at Agricultural Fairs.Nasal Wipes for Influenza A Virus Detection and Isolation from Swine.Scientific opinion on the possible risks posed by the influenza A (H3N2v) virus for animal health and its potential spread and implications for animal and human healthThe Unexpected Impact of Vaccines on Secondary Bacterial Infections Following Influenza.Chronic wasting disease management in ranched elk using rectal biopsy testing.Universal Vaccines and Vaccine Platforms to Protect against Influenza Viruses in Humans and Agriculture.Detection of influenza A virus in aerosols of vaccinated and non-vaccinated pigs in a warm environment.Comparison of Heterosubtypic Protection in Ferrets and Pigs Induced by a Single-Cycle Influenza Vaccine.Zoonotic Potential of Influenza A Viruses: A Comprehensive OverviewAn alternative strategy as a quadrivalent live attenuated influenza virus vaccineColonization Limits Efficacy, but Not Immunogenicity, of Live-Attenuated Influenza Virus Vaccine and Enhances Pathogenesis After Influenza Challenge
P2860
Q26783503-08220A93-15C9-451E-BC6C-FF2A8FD32491Q27322031-F321DB2E-1470-4528-B32F-2AE4C43CAA99Q30151518-79E5DD53-A223-41AD-901E-1C5DEC27330DQ30234558-724DA390-8AA9-4498-ABDB-E2325FA5A87FQ30370471-7FE0306F-2657-4AEC-B5AD-7292F51A55CAQ30384443-CD1F7535-76C8-4662-9826-6EE3ED8B78BFQ30385957-4AE9305D-A8D0-474A-9182-906B51CFDAB2Q30386279-D8A2286C-B463-42B1-8789-9169F53AA952Q30388110-A228301F-1F69-4278-8E57-C5C1E06BD587Q30394336-30454AEE-D752-404E-AE3B-53F17464735BQ30396591-FDD85E96-5665-447B-A3CA-1DA84F36B169Q33733453-9AC3F4E6-4FE7-4A0A-A9F0-B0E41E977E2AQ36087562-F75AEA9C-8416-4D9E-BE9E-A3B68D0C0F8EQ37182410-8EFF7436-6085-418C-8BBD-96155139E70EQ37224897-278BB37A-C639-4B43-B734-26D9C9B28BB5Q37554823-75A656AA-AB0B-4C0A-BC3A-990CB62A2E56Q37713949-82BA17B6-3174-4B94-B085-5D6C8659110BQ40838623-6FFAD440-451F-4BAB-93AF-AB71AB2D5F21Q40855270-A242C97E-333B-4667-9D59-B7712A8F44BFQ47153755-9E49E6F0-631E-4012-86EE-0082D6783A3AQ47576940-E2D5A392-2C68-45B5-835E-DB7DFD8FFDEBQ48504611-E7625771-AEB7-45F8-BB4D-42B1A879340DQ50308620-DBD5BF54-DF34-46F8-A4B9-3D8F5B9304F3Q54204353-E3F93698-8C2E-46FE-84E8-F2BC863956D6Q54226450-DF60CAA6-67D6-40AC-87A0-C188196F8C05Q57093653-28719470-0714-4C36-BC5E-4E780F691AECQ57093877-E384EF7B-671A-4E81-9078-F506119B1B51Q58583885-09E3EFB3-6D9C-4344-AA51-97FD9B390BF3
P2860
Efficacy in pigs of inactivated and live attenuated influenza virus vaccines against infection and transmission of an emerging H3N2 similar to the 2011-2012 H3N2v.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Efficacy in pigs of inactivate ...... imilar to the 2011-2012 H3N2v.
@en
Efficacy in pigs of inactivate ...... imilar to the 2011-2012 H3N2v.
@nl
type
label
Efficacy in pigs of inactivate ...... imilar to the 2011-2012 H3N2v.
@en
Efficacy in pigs of inactivate ...... imilar to the 2011-2012 H3N2v.
@nl
prefLabel
Efficacy in pigs of inactivate ...... imilar to the 2011-2012 H3N2v.
@en
Efficacy in pigs of inactivate ...... imilar to the 2011-2012 H3N2v.
@nl
P2093
P2860
P50
P356
P1433
P1476
Efficacy in pigs of inactivate ...... imilar to the 2011-2012 H3N2v.
@en
P2093
Amy L Vincent
Crystal L Loving
Kelly M Lager
Phillip C Gauger
Pravina Kitikoon
Susan L Brockmeier
P2860
P304
P356
10.1128/JVI.01038-13
P407
P577
2013-07-03T00:00:00Z